Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.

Wassermann J, Gelber SI, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, Borges VF, Come SE, Meyer ME, Partridge AH.

Cancer. 2019 May 23. doi: 10.1002/cncr.32192. [Epub ahead of print]

PMID:
31120571
2.

Cardiac arrhythmia considerations of hormone cancer therapies.

Barber M, Nguyen LS, Wassermann J, Spano JP, Funck-Brentano C, Salem JE.

Cardiovasc Res. 2019 Apr 15;115(5):878-894. doi: 10.1093/cvr/cvz020.

PMID:
30698686
3.

In reply.

Quaas J, Saul T, Wassermann J, Davey K.

Ann Emerg Med. 2019 Jan;73(1):98-99. doi: 10.1016/j.annemergmed.2018.09.006. No abstract available.

PMID:
30577965
4.

Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer.

Borson-Chazot F, Dantony E, Illouz F, Lopez J, Niccoli P, Wassermann J, Do Cao C, Leboulleux S, Klein M, Tabarin A, Eberle MC, Benisvy D, de la Fouchardière C, Bournaud C, Lasolle H, Delahaye A, Rabilloud M, Lapras V, Decaussin-Petrucci M, Schlumberger M.

Thyroid. 2018 Sep;28(9):1174-1179. doi: 10.1089/thy.2017.0663.

PMID:
30105951
5.

Application of the Canadian Computed Tomography Head Rule to Patients With Minimal Head Injury.

Davey K, Saul T, Russel G, Wassermann J, Quaas J.

Ann Emerg Med. 2018 Oct;72(4):342-350. doi: 10.1016/j.annemergmed.2018.03.034. Epub 2018 May 10.

PMID:
29753518
6.

The AlpArray Seismic Network: A Large-Scale European Experiment to Image the Alpine Orogen.

Hetényi G, Molinari I, Clinton J, Bokelmann G, Bondár I, Crawford WC, Dessa JX, Doubre C, Friederich W, Fuchs F, Giardini D, Gráczer Z, Handy MR, Herak M, Jia Y, Kissling E, Kopp H, Korn M, Margheriti L, Meier T, Mucciarelli M, Paul A, Pesaresi D, Piromallo C, Plenefisch T, Plomerová J, Ritter J, Rümpker G, Šipka V, Spallarossa D, Thomas C, Tilmann F, Wassermann J, Weber M, Wéber Z, Wesztergom V, Živčić M; AlpArray Seismic Network Team; AlpArray OBS Cruise Crew; AlpArray Working Group.

Surv Geophys. 2018;39(5):1009-1033. doi: 10.1007/s10712-018-9472-4. Epub 2018 Apr 18. Review.

7.

Clinical pharmacology of anti-angiogenic drugs in oncology.

Gougis P, Wassermann J, Spano JP, Keynan N, Funck-Brentano C, Salem JE.

Crit Rev Oncol Hematol. 2017 Nov;119:75-93. doi: 10.1016/j.critrevonc.2017.08.010. Epub 2017 Sep 1. Review.

PMID:
28916378
8.

Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.

Wassermann J, Bernier MO, Spano JP, Lepoutre-Lussey C, Buffet C, Simon JM, Ménégaux F, Tissier F, Leban M, Leenhardt L.

Oncologist. 2016 Jan;21(1):50-8. doi: 10.1634/theoncologist.2015-0107. Epub 2015 Dec 16.

9.

Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging.

Bouattour M, Payancé A, Wassermann J.

World J Hepatol. 2015 Sep 18;7(20):2245-63. doi: 10.4254/wjh.v7.i20.2245. Review.

10.

Negative Trials for Foreseeable Safety Reasons in Advanced Hepatocellular Carcinoma: How Long Are We Going to Take Lightly Pharmacokinetics of Tyrosine Kinase Inhibitors?

Bouattour M, Rousseau B, Wassermann J, Payancé A, Huillard O.

J Clin Oncol. 2015 Aug 1;33(22):2484-5. doi: 10.1200/JCO.2014.60.6954. Epub 2015 Jun 1. No abstract available.

PMID:
26033820
11.

Sorafenib in thyroid cancer patients: learning from toxicity.

Huillard O, Blanchet B, Boudou-Rouquette P, Thomas-Schoemann A, Wassermann J, Goldwasser F.

Oncologist. 2014 Aug;19(8):e3. doi: 10.1634/theoncologist.2014-0156. Epub 2014 Jul 22. No abstract available.

12.

Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib.

Ronot M, Bouattour M, Wassermann J, Bruno O, Dreyer C, Larroque B, Castera L, Vilgrain V, Belghiti J, Raymond E, Faivre S.

Oncologist. 2014 Apr;19(4):394-402. doi: 10.1634/theoncologist.2013-0114. Epub 2014 Mar 20.

13.

[Young oncologists to the service tomorrow's cancerology].

Wassermann J, Bellesoeur A.

Bull Cancer. 2013 Dec;100(12):1233-4. French. No abstract available.

PMID:
24516898
14.

[Vitamin D and cancers].

Espié M, Wassermann J, de Kermadec E, Lalloum M, Coussy F.

Presse Med. 2013 Oct;42(10):1405-11. doi: 10.1016/j.lpm.2013.07.013. Epub 2013 Sep 17. Review. French.

PMID:
24051164
15.

Bezoar.

Yeh J, Saul T, Gingrich A, Wassermann J.

J Emerg Med. 2013 Oct;45(4):615-6. doi: 10.1016/j.jemermed.2013.02.003. Epub 2013 Jul 26. No abstract available.

PMID:
23890688
16.

Acute refractory hypoxemia after chest trauma reversed by high-frequency oscillatory ventilation: a case report.

Charbonney E, Tsang JL, Wassermann J, Adhikari NK.

J Med Case Rep. 2013 Jul 15;7:186. doi: 10.1186/1752-1947-7-186.

17.

Segmental dosimetry, toxicity and long-term outcome in patients with prostate cancer treated with permanent seed implants.

Meyer A, Wassermann J, Warszawski-Baumann A, Baumann R, Machtens S, Karstens JH, Christiansen H, Merseburger A, Kuczyk MA, von Klot C.

BJU Int. 2013 May;111(6):897-904. doi: 10.1111/j.1464-410X.2012.11558.x. Epub 2013 Jan 10.

18.

Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series.

Rodrigues MJ, Peron J, Frénel JS, Vano YA, Wassermann J, Debled M, Picaud F, Albiges L, Vincent-Salomon A, Cottu PH.

Ann Oncol. 2013 Apr;24(4):916-24. doi: 10.1093/annonc/mds536. Epub 2012 Oct 26.

PMID:
23104720
19.

Evaluating the risk-benefit ratio of adjuvant trastuzumab-based therapy for T1a,bN0M0 HER2-positive breast carcinomas.

Rodrigues MJ, Albiges-Sauvin L, Wassermann J, Cottu PH.

Ann Oncol. 2011 Nov;22(11):2530. doi: 10.1093/annonc/mdr308. Epub 2011 Jun 23. No abstract available.

PMID:
21700734
20.

Internet to boost patient accrual in oncology trials? A multiinstitutional AERIO study.

Rodrigues MJ, Haberer S, Dionysopoulos D, Barrière J, Wassermann J, Tazi Y, Rajpar S, Giroux J, Bidard FC, Loriot Y; AERIO Group.

Ann Oncol. 2011 Feb;22(2):490-1. doi: 10.1093/annonc/mdq746. Epub 2011 Jan 19. No abstract available.

PMID:
21248065

Supplemental Content

Loading ...
Support Center